45-101 : Drug Use-Results Survey of ONOACT

JRCT ID: jRCT2041240118

Registered date:05/11/2024

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: tachyarrhythmias associated with sepsis: atrial fibrillation, atrial flutter, sinus tachycardia
• Date of first enrollment: 09/01/2021
• Target sample size: 200
• Study type: Observational

Outcome(s)

• Primary Outcome: Safety items : Occurrence of adverse drug reactions and infections set as safety specifications, factors considered to influence the safety, background factors that may influence life prognosis

Key inclusion & exclusion criteria

• Age minimum: Not applicable
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Patients with the following tachyarrhythmias associated with sepsis: atrial fibrillation, atrial flutter, sinus tachycardia, who have recieved ONOACT for the first time
• Exclude criteria: Patients who have received ONOACT previously

Related Information

• Primary Sponsor: Kuro Toshihiko